Abstract
We recently demonstrated the role of M1 muscarinic receptors (M1R) in modulating oxidative stress in liver and hepatocytes (Urrunaga et al., 2015) [1]. Here we provide data regarding the effect of a novel M1R agonist, VU0357017 (Lebois et al., 2010) [2], on H2O2-mediated hepatocyte injury, the effect of an M1R antagonist VU0255035 (Sheffler et al., 2009) [3] on catalase and super oxide dismutase (SOD) activities in H2O2–treated hepatocytes in vitro, and finally, the effect of M1R ablation on hepatic catalase activity in acetaminophen (APAP)-treated mice.
Keywords: Muscarinic receptors, Oxidative stress, Catalase
Specifications Table
| Subject area | Biology |
|---|---|
| More specific subject area | M1 muscarinic receptors and oxidative stress |
| Type of data | Figures |
| How data was acquired | BioMate 3S Spectrophotometer and Versa Max micro-plate reader |
| Data format | Analyzed |
| Experimental factors | No pretreatment |
| Experimental features | Enzyme activity and cytotoxicity assay |
| Data source location | Medical College of Georgia, Augusta, GA |
| Data accessibility | The data are supplied with this article |
Value of the data
In response to oxidative stress:
-
•
In contrast to M1R inhibition that reduces hepatocyte injury [1], M1R activation has no effect.
-
•
In addition to enhancing GSH recovery [1], M1R inhibition enhances hepatic catalase activity.
-
•
However, M1R inhibition has no effect on hepatocyte SOD activity.
1. Data
Previously we showed in mice that M1R ablation reduces APAP-induced liver injury by preventing GSH depletion and peroxynitrite generation, thereby reducing hepatocyte necrosis [1]. We also showed that in AML12 hepatocytes (the non-transformed mouse hepatocytes), VU0255035 an M1R antagonist [3], reduced H2O2-mediated necrosis, an effect abrogated by inhibition of GCLC, the key GSH generating enzyme. Here, we show that unlike M1R antagonist (VU0255035) [1], the novel M1R agonist (VU0357017) [2] did not alter H2O2-induced cytotoxicity ( Fig. 1). In hepatocytes incubated with H2O2, VU0255035 augmented catalase activity but had no effect on SOD activity (Fig. 2). Finally, in mice, 2 h after APAP overdose, hepatic catalase activity decreased; however, after 4 h, compared to wild type (WT) mice, catalase activity improved significantly in the livers of M1R-deficient (Chrm1−/−) mice (Fig. 3).
Fig. 1.
Effect of an M1R agonist (VU0357017) on H2O2-induced cytotoxicity assessed by MTT assay. (A) Incubation with 1 mM H2O2 for 6 h markedly reduced AML12 hepatocyte viability. (B) Treatment with VU0357017 (0.3–3.0 µM) alone had no effect on hepatocyte viability. Results are mean±S.E.M. ns: not significant.
Fig. 2.
Effects of a highly selective M1R antagonist VU0255035, on catalase and SOD activities were assessed in AML12 hepatocytes treated with 1 mM H2O2 for 120 min. Compared to cells treated with vehicle (DMSO) alone, catalase and SOD activities were significantly reduced in H2O2-treated cells. Co-treatment with VU0255035 improved catalase activity (A), but had no effect on SOD activity (B). (C) VU0255035 alone had no effect on cell viability. Results are mean±S.E.M. * P<0.05, ** P<0.01.
Fig. 3.

Effect of M1R ablation on APAP-induced changes in hepatic catalase activity. WT and Chrm1−/− mice were fasted overnight and treated with APAP 200 mg/kg intraperitoneally in the morning. Two and 4 h after APAP injection, mice were euthanized and their livers harvested and analyzed as described previously [1]. By 2 h, hepatic catalase activity reduced significantly in all APAP-treated mice. However, by 4 h, catalase activity was significantly higher in the livers of Chrm1−/− mice when compared to WT mice. Results are mean±S.E.M. * P<0.05.
2. Experimental design, materials and methods
2.1. Experimental animals
Animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals prepared by the United States National Academy of Sciences (National Institutes of Health), approved by the Institutional Animal Care and Use Committee, and described in detail previously [1]. The stored liver tissue from the Chrm1−/− and WT mice were used to assess catalase activity.
2.2. AML12 cell culture
AML12, a non-tumorigenic mouse hepatocyte cell line (ATCC, USA), was cultured at 37 °C with 5% CO2 in a 1:1 mixture of Dulbecco׳s modified Eagle׳s and Ham׳s F12 medium with 0.005 mg/ml insulin, 0.005 mg/ml transferrin, 5 ng/ml selenium, and 10% fetal bovine serum. Cells were sub-cultured (1:4 to 1:6) using a 0.25% (w/v) trypsin-0.53 mM EDTA solution.
2.3. Cytotoxicity assay
AML12 cells (6.0×103 cells/well) were cultured in 96-well plates in the presence of 1 mM H2O2 plus vehicle (DMSO) or VU0357017 (0.3–3 μM) (PubChem CID: 25010775), the M1R agonist (Tocris, USA). After 6 h, the culture media was replaced with 100 μl MTT (0.5 mg/ml in culture media) and incubated at 37 °C. After 2.5 h, the MTT solution was discarded, all wells washed with PBS, and added 150 μl DMSO each. The plate was kept at room temperature for 30 min with constant shaking, and absorbance read at 540 nm (VersaMax Microplate Reader, Molecular Device).
2.4. Preparation of cell extracts
AML12 cells (1×105 cells/well) were maintained in six-well plates in the presence of 1 mM H2O2 and vehicle or 1 µM VU0255035 (PubChem CID: 24768606). After 2 h, cells were lysed using a polytron homogenizer using isolation buffer (250 mM sucrose, 10 mM Tris HCL pH 7.4, and 0.1 mM EGTA).
2.5. Superoxide dismutase activity assay
SOD activity was estimated as described previously [4]. Reaction mixture contained 0.1 ml phenazine methosulphate (186 μM), 1.2 ml sodium pyrophosphate buffer (0.052 mM, pH 7.0) and 0.3 ml cell supernatant. Enzyme reaction was initiated by adding 0.2 ml NADH (780 μM) and terminated after 1 min by adding 1 ml glacial acetic acid. The chromogen formed was assessed by measuring absorbance at 560 nm on BioMate 3S Spectrophotometer (Thermo Scientific, USA). Results are expressed in units/mg protein.
2.6. Catalase activity assay
Catalase activity was assessed in cellular and tissue fractions as described earlier [5]. Briefly, the activity was determined by measuring the decrease in absorbance at 240 nm of a reaction mixture consisting H2O2 in phosphate buffer, pH 7.0, and cellular/tissue extracts. The molar extinction coefficient of 43.6 M cm−1 was used to determine catalase activity and expressed as units/mg protein.
2.7. Statistical analysis
All data are expressed as mean±S.E.M. Normality was determined using the Shapiro–Wilk test. Student׳s t-test (normally distributed data) or the Mann–Whitney U test (nonparametric data) was used to determine significance. Analysis was performed using SigmaPlot (version 12.0; Systat Software, Inc. San Jose, CA). Significance was defined as P<0.05.
Acknowledgments
This work was supported by the NIH (K08DK081479) and the Department of Medicine at the Medical College of Georgia. We thank Dr. Michael Duncan (Medical College of Georgia) for providing AML12 cells, and Dr. Jürgen Wess (NIDDK) for providing Chrm1−/− and wild type mice.
Footnotes
Supplementary data associated with this article can be found in the online version at doi:10.1016/j.dib.2015.12.025.
Appendix A. Supplementary material
Supplementary material
References
- 1.Urrunaga N.H., Jadeja R.N., Rachakonda V., Ahmad D., McLean L.P., Cheng K., Shah V., Twaddell W.S., Raufman J.P., Khurana S. M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury. Free Radic. Biol. Med. 2015;78:66–81. doi: 10.1016/j.freeradbiomed.2014.09.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lebois E.P., Bridges T.M., Lewis L.M., Dawson E.S., Kane A.S., Xiang Z., Jadhav S.B., Yin H., Kennedy J.P., Meiler J., Niswender C.M., Jones C.K., Conn P.J., Weaver C.D., Lindsley C.W. Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. ACS Chem. Neurosci. 2010;1:104–121. doi: 10.1021/cn900003h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sheffler D.J., Williams R., Bridges T.M., Xiang Z., Kane A.S., Byun N.E., Jadhav S., Mock M.M., Zheng F., Lewis L.M., Jones C.K., Niswender C.M., Weaver C.D., Lindsley C.W., Conn P.J. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning. Mol. Pharmacol. 2009;76:356–368. doi: 10.1124/mol.109.056531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide-dismutase. Indian J. Biochem. Biophys. 1984;21:130–132. [PubMed] [Google Scholar]
- 5.Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126. doi: 10.1016/s0076-6879(84)05016-3. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary material


